A guide to GRADE guidelines for the readers of JTH

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 8, 2013, Pages 1603-1608

  Guyatt, G ^a   Eikelboom, J W ^a   Akl, E A ^a   Crowther, M ^a   Gutterman, D ^b   Kahn, S R ^c   Schunemann, H ^a   Hirsh, J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Antithrombotic agents; Aspirin; Conflict of interest; Evidence based medicine; Guidelines

Indexed keywords

ARTICLE; AWARENESS; CONFLICT OF INTEREST; FINANCE; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; ORGANIZATION; OUTCOMES RESEARCH; PATIENT DECISION MAKING; PHYSICIAN; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; READING; SOCIAL DESIRABILITY; WEAKNESS;

ANTITHROMBOTIC AGENTS; ASPIRIN; CONFLICT OF INTEREST; EVIDENCE-BASED MEDICINE; GUIDELINES;

ASPIRIN; DECISION MAKING; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HEMATOLOGY; HUMANS; INTERNATIONAL COOPERATION; PRACTICE GUIDELINES AS TOPIC; REVIEW LITERATURE AS TOPIC; SOCIETIES, MEDICAL; TREATMENT OUTCOME; UNITED STATES;

EID: 84881600148     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12320     Document Type: Article

References (20)

1. Kung J, Miller RR, Mackowiak PA. Failure of clinical practice guidelines to meet institute of medicine standards: two more decades of little, if any, progress. Arch Intern Med 2012; 172: 1628-33.
2. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.
3. Guyatt GH, Norris SL, Schulman S, Hirsh J, Eckman MH, Akl EA, Crowther M, Vandvik PO, Eikelboom JW, McDonagh MS, Lewis SZ, Gutterman DD, Cook DJ, Schunemann HJ. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012; 141(Suppl. 2): 53S-70S.
4. Cohen A. There's madness in their methods - a response to: venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting. J Thromb Haemost 2013; 11: 782-5.
5. World health organization. Medical eligibility for contraceptive Use. 4th ed. World Health Organization, 2009. Available from: http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf. Accessed 11 May 2013.
6. MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, McLeod S, Bhatnagar N, Guyatt GH. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl. 2): e1S-23S.
7. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. BMJ 2002; 324: 723-9.
8. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med 2007; 356: 1742-50.
9. Steinbrook R. Controlling conflict of interest-proposals from the Institute of Medicine. N Engl J Med 2009; 360: 2160-3.
10. Marshall E. When does intellectual passion become conflict of interest? Science 1992; 257: 620-3.
11. Schunemann HJ, Osborne M, Moss J, Manthous C, Wagner G, Sicilian L, Ohar J, McDermott S, Lucas L, Jaeschke R. An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med 2009; 180: 564-80.
12. Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM, Albert NM, Antman EM, Arnett DK, Bertolet M, Bhatt DL, Brindis RG, Creager MA, DeMets DL, Dickersin K, Fonarow GC, Gibbons RJ, Halperin JL, Hochman JS, Koster MA, et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: 268-310.
13. Qaseem A, Snow V, Owens DK, Shekelle P. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med 2010; 153: 194-9.
14. Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, Lewis SZ, Nathanson I, Jaeschke R, Schunemann H. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 2010; 152: 738-41.
15. Kopp C. Independence: What's the point? Or "How to choose an acceptable dependence?". International Society of Drug Bulletins, 2005. Available from: http://www.isdbweb.org/documents/uploads/Independence_000.pdf. Accessed 11 May 2013.
16. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011; 64: 380-2.
17. Guyatt GH, Eikelboom JW, Gould MK, Garcia DA, Crowther M, Murad MH, Kahn SR, Falck-Ytter Y, Francis CW, Lansberg MG, Akl EA, Hirsh J. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl. 2): e185S-94S.
18. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(Suppl. 6): 381S-453S.
19. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl. 2): e278S-325S.
20. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295-302.